Autonomic Testing: Common Methods and What They Show

Updated: May 15, 2026

Autonomic testing is a set of standardized clinical assessments that evaluate how the autonomic nervous system regulates cardiovascular, sudomotor, and other physiological responses to defined stimuli.¹ That definition is precise by design. Autonomic testing is not a loose category of wellness screenings; it is a structured technical discipline with validated protocols, age-adjusted reference ranges, and a clear separation between what each individual test can and cannot show.

It is a category of tests, not a single measurement. A complete autonomic testing battery may include cardiovascular reflex tests, heart rate variability (HRV), sudomotor assessment, and orthostatic stress protocols. The goal is not one number but a pattern: how sympathetic and parasympathetic pathways respond under controlled, repeatable conditions, and where those responses deviate from what is expected for a given age and health profile.

What autonomic testing is and why clinicians use it

The autonomic nervous system manages processes you do not consciously control: heart rate, blood pressure, sweating, respiration-linked cardiac modulation, and vascular tone. Two major branches divide that responsibility. The sympathetic branch drives arousal responses and vasoconstriction. The parasympathetic branch, especially vagal input to the sinoatrial node, slows the heart and supports beat-to-beat flexibility. When those branches fall out of calibration, signs often appear in reflex timing, orthostatic stability, or sweat output before they become obvious in routine clinical measurements. For a primer on how those branches differ and interact, see sympathetic vs parasympathetic: signal quality and measurement limits.

Clinicians order autonomic testing when symptoms or objective findings suggest impaired reflex control, orthostatic intolerance, peripheral autonomic neuropathy, or abnormal sudomotor function. Researchers use it to quantify autonomic modulation under repeatable conditions rather than relying on symptom reports alone. Both uses share a core requirement: standardized protocols. That requirement matters because autonomic outputs are not static. Posture, breathing rate, age, medications, temperature, and recording method all shift the baseline, which means uncontrolled measurements produce uninterpretable numbers.²

What abnormal autonomic testing results actually indicate

A positive finding on autonomic testing tells you which reflex arc showed reduced or absent response under controlled conditions. It does not, on its own, identify the cause or dictate a specific treatment path. That distinction matters because autonomic dysfunction appears across a wide range of diagnoses — diabetic neuropathy, Parkinson disease, multiple system atrophy, pure autonomic failure, autoimmune autonomic ganglionopathy, and syndromes like postural orthostatic tachycardia — and the reflex profile can look similar across conditions with very different underlying pathophysiology.¹¹

The Ewing battery scoring system categorizes findings as normal, borderline, or abnormal based on how many of the five tests fall outside age-adjusted reference ranges. A patient with two or more clearly abnormal tests shows a different autonomic risk profile than someone with a single borderline result, and clinical interpretation takes that gradient into account. Isolated abnormalities in one test carry different weight than a diffuse pattern across cardiac and vasomotor tests. Similarly, a preserved cardiovascular reflex battery alongside abnormal sudomotor findings points toward a different distribution of dysfunction than the reverse pattern.

Where tilt table testing produces a clear positive result — a sustained heart rate increase meeting protocol criteria, or documented orthostatic hypotension with symptom reproduction — that result supports but does not independently establish a diagnosis. The same pattern appears in dehydration, deconditioning, prolonged bed rest, and some medication effects.¹² Clinical autonomic laboratories use the test result as one input into an interpretation framework that includes symptom history, physical examination findings, medication review, and repeat testing when the initial picture is ambiguous.

HRV findings within an autonomic evaluation follow a similar logic. A low RMSSD relative to age-matched reference data suggests reduced cardiac vagal modulation, but that observation requires context before it adds clinical information. Is the recording technically clean? Was the patient on a beta blocker? Did breathing rate change during the recording window? Was the measurement taken within two hours of waking, during a period of acute illness, or after a night of significantly disrupted sleep? Each of those factors can shift HRV by clinically meaningful amounts without reflecting a change in underlying autonomic function at all.⁴

None of this makes autonomic testing less useful. It makes it more useful when interpreted correctly. The protocols are standardized precisely so that results across different laboratories and testing sessions can be compared. A finding of borderline Valsalva ratio in a patient with suspected early diabetic neuropathy, followed six months later by a clearly abnormal result on the same test, tells you something meaningful about trajectory. That longitudinal comparison is only possible because the protocol is consistent — not because any single time point resolves the diagnostic question on its own.

Autonomic testing in research and longitudinal monitoring

Most published autonomic research is built on two modalities: formal laboratory testing and HRV measurement. Each fills a different role. Laboratory autonomic testing provides high-resolution characterization of specific reflex arcs under controlled conditions. HRV from continuous wearable PPG provides temporal density that a single laboratory visit cannot approach — days and weeks of beat-to-beat signal reflecting how autonomic modulation shifts with sleep, activity, recovery, and illness.¹³ These two approaches are not competing frameworks. They answer different questions.

Research protocols increasingly combine them: a baseline autonomic laboratory evaluation to establish individual reflex profiles, followed by longitudinal PPG monitoring to track HRV trends over intervention periods. That combination is particularly useful in clinical studies of exercise training, pharmacological interventions, and behavioral protocols where the question is not just whether autonomic function is abnormal at baseline but whether and how it changes over time. A single tilt table test captures one morning’s orthostatic response. Daily HRV monitoring shows how that response evolves across weeks of training or recovery.

The technical requirement for this combination is signal quality at every level. In the laboratory, that means standardized protocol adherence, controlled breathing, appropriate patient preparation, and validated equipment. In continuous monitoring, it means effective artifact rejection, transparent handling of data gaps, and reference to age-matched normative values when interpreting individual HRV trajectories. PPG platforms that provide raw waveform access rather than pre-processed proprietary scores give researchers and clinicians the signal layer they need to apply their own quality filters and analytical frameworks, which is especially important when research protocols require transparency about how each beat was classified and what was excluded.⁸

Population-specific norms are a persistent methodological challenge in both settings. HRV values change substantially across the adult lifespan, with RMSSD and high-frequency power declining with age even in healthy individuals.¹⁰ Cardiovascular reflex amplitudes follow a similar age trajectory. Reference ranges derived from young adult populations cannot be applied to older adults without correction, and this issue is not always clearly addressed in published autonomic research. For longitudinal tracking within an individual — where the comparison is to that person’s own baseline rather than to a population norm — age effects matter less than consistency in measurement conditions. That is one reason individual-referenced longitudinal monitoring is attracting research attention alongside population-normed single-session testing.

Cardiovascular reflex testing: the Ewing battery

The Ewing battery is the foundational cardiovascular reflex framework in clinical autonomic testing. Understanding its structure helps illustrate how the field separates parasympathetic from sympathetic function. The battery includes five tests: heart rate response to deep breathing, the Valsalva ratio, the 30:15 heart rate ratio after standing, systolic blood pressure fall on standing, and diastolic blood pressure response to sustained handgrip.³ That is not an arbitrary list. Each maneuver stresses a specific reflex arc rather than treating autonomic function as a single global score, which makes individual test results far more interpretable when findings are abnormal.

Deep breathing and the Valsalva heart rate response primarily probe parasympathetic cardiac modulation. Standing blood pressure and sustained handgrip responses primarily probe sympathetic vasomotor control. The battery was originally developed for diabetic autonomic neuropathy assessment, and its structure has since shaped the design of broader clinical autonomic laboratories. Results are scored against age-adjusted reference ranges because normal reflex amplitude declines across adulthood. What counts as a healthy heart rate response to deep breathing at 30 differs meaningfully from the expected response at 65. That calibration requirement is one reason clinical autonomic testing cannot be replicated by uncalibrated monitoring alone.

Heart rate variability as an autonomic testing tool

Heart rate variability is the variation in time intervals between successive heartbeats. In autonomic testing, HRV provides a non-invasive index of cardiac autonomic modulation, particularly vagally mediated parasympathetic activity. Time-domain metrics include RMSSD, SDNN, and pNN50. Frequency-domain metrics include low-frequency power, high-frequency power, and the LF/HF ratio, although the ratio is contested and treating it as a simple sympathovagal balance marker misrepresents what the data actually shows.⁴ RMSSD and high-frequency HRV are the more defensible vagal indices under controlled breathing and resting conditions.⁵

HRV should not be read as a stand-alone diagnostic test. Age, respiratory rate, posture, circadian timing, sleep, medications, and signal quality all shift measured HRV values. If you have encountered the idea that a higher number is always better, that framing skips the context-dependence that makes the metric useful in the first place. For what vagal tone indices actually represent and where their limits sit, see vagal tone meaning: signal, noise, and measurement limits. For the relationship between HRV and resting heart rate as complementary signals, see HRV vs resting heart rate. If you are looking for evidence-based approaches to improving HRV over time, how to raise heart rate variability: practical steps backed by research covers the published interventions in detail.

Sudomotor function testing: QSART and thermoregulatory sweating

Sudomotor testing evaluates sympathetic pathways that control sweat glands, and it fills a gap that cardiovascular reflex tests cannot cover on their own. The quantitative sudomotor axon reflex test (QSART) uses acetylcholine iontophoresis to stimulate postganglionic sudomotor axons, then measures sweat output from standardized body sites. The thermoregulatory sweat test maps whole-body sweating under a controlled thermal load using indicator powder that changes color with moisture. Together, these two tests reveal patterns of sympathetic sudomotor dysfunction across different skin regions and body segments.

That regional granularity matters. A patient can have clearly abnormal sweating with relatively preserved heart rate and blood pressure reflexes. The sympathetic pathways serving sweat glands and those serving the cardiovascular system do not always fail in parallel, and assuming they do can lead to incomplete assessment. Sudomotor testing is therefore especially useful when evaluating small-fiber autonomic involvement and length-dependent peripheral patterns, where distal sympathetic fibers are affected before more proximal ones.⁶ These tests require specialized laboratory equipment and trained technicians. They cannot be approximated by HRV measurement or optical waveform analysis, and that is not a limitation of those tools: it is simply a description of what each method is designed to measure.

Tilt table testing and orthostatic stress protocols

Tilt table testing is a controlled orthostatic stress protocol that evaluates cardiovascular autonomic regulation under defined gravitational challenge. The patient begins supine, then moves passively to a head-up position, commonly 60 to 80 degrees, while heart rate and blood pressure are recorded continuously. That passive tilt removes the muscular activation of active standing, which makes hemodynamic responses more interpretable and more reproducible across test sessions. Put simply, you are removing a confound, not just repositioning the patient.

The test helps characterize patterns consistent with orthostatic hypotension, vasovagal syncope, or postural orthostatic tachycardia syndrome. Consensus criteria define the tachycardia pattern by a sustained heart rate increase of at least 30 beats per minute in adults, or 40 beats per minute in adolescents, without orthostatic hypotension.⁷ That specificity is deliberate: the criteria exist to distinguish a reflex autonomic pattern from normal orthostatic heart rate adjustments, which is a subtler distinction than it may appear on the surface. Formal tilt protocols require validated hemodynamic measurement, controlled setup, and clinical interpretation. The procedure is an evaluation framework, not a substitute for continuous consumer monitoring.

How autonomic testing is measured at the signal level

Autonomic testing depends on accurate signal timing and waveform quality. ECG is the reference standard for HRV because the R peak provides a precise electrical timing marker with millisecond resolution. Photoplethysmography (PPG) measures optical blood-volume changes in tissue and estimates pulse-to-pulse intervals from the waveform peak or foot. Those two approaches are not interchangeable. PPG-derived HRV can correlate with ECG-derived HRV during controlled resting recordings, but motion artifact, vasoconstriction, poor sensor contact, arrhythmia, and insufficient sampling rate all reduce agreement under real-world conditions.⁸ The same signal-quality constraints that apply during laboratory recordings become even more consequential during sleep and free-living monitoring, as discussed in high heart rate during sleep: signal quality and measurement limits.

That distinction matters for understanding where continuous PPG monitoring fits and where it does not. Continuous PPG can support longitudinal biosignal research and remote therapeutic monitoring (RTM) workflows, providing trend data across days and weeks that a single laboratory visit cannot capture. What it cannot do is substitute for validated clinical protocols in formal autonomic testing. The appropriate role of each modality depends on the question being asked. For a direct comparison of these measurement approaches, see PPG vs ECG vs pulse oximetry, and for the broader scientific framework, see Sensor Bio science.

PPG vs ECG: trade-offs

ECG and PPG answer different measurement needs. Comparing them is only useful when you frame the comparison around those specific needs rather than asking which one is universally better. ECG gives higher timing precision and better rhythm visibility, making it the reference modality for formal HRV analysis, Valsalva assessment, and cardiovascular reflex protocols. PPG provides optical pulse-wave data that can support longer, less obtrusive monitoring outside the laboratory, which is a meaningful practical advantage when you need weeks of continuous signal rather than a 45-minute laboratory session.

The trade-off is signal vulnerability. PPG waveform quality varies with peripheral perfusion, sensor placement, motion artifact, and individual skin optical properties. ECG is harder to deploy continuously at scale but produces cleaner beat-timing data for formal clinical assessment. PPG is easier to wear continuously but requires strict quality filtering and transparent handling of artifact periods. In controlled resting conditions, PPG-derived HRV may be suitable for research-grade longitudinal observation. It should not be presented as equivalent to ECG across all clinical autonomic testing contexts, and any reporting framework that implies otherwise creates a misleading picture of measurement precision.⁵

Limits and pitfalls when interpreting autonomic testing

Autonomic testing results are always context-dependent, and understanding that context is what separates a useful interpretation from a misleading one. HRV is not a pure measure of vagal tone, and the LF/HF ratio should not be treated as a simple sympathetic-parasympathetic balance score.⁹ Respiratory rate, tidal volume, posture, medications, caffeine, sleep, hydration, age, sex, and recording duration all change measured outputs. Two people with identical underlying physiology can produce very different HRV numbers if their breathing patterns differ during recording. That variability is not a flaw in the metric; it is a property of how autonomic modulation actually works.

Population reference ranges introduce another layer of complexity. Short-term RMSSD values in older adults cannot be interpreted against young-adult reference data because normal values shift substantially across the lifespan.¹⁰ One-time laboratory autonomic testing can also miss episodic dysfunction, particularly in conditions where autonomic dysregulation is intermittent rather than persistent. Continuous monitoring adds temporal resolution that single-visit testing cannot provide, but it also introduces artifact and signal-quality challenges that must be actively managed rather than ignored. The strongest interpretation of autonomic function comes from protocol consistency, age-matched reference data, multi-domain testing, and clinical correlation. No single metric, not RMSSD, not LF/HF, not beat-to-beat blood pressure response, resolves the full picture on its own. For related context on how overnight autonomic signals behave and what measurement limits apply, see low heart rate during sleep: signal, noise, and measurement limits.

FAQ

What is autonomic testing used for clinically?

Autonomic testing is used to assess autonomic nervous system function when symptoms or findings suggest impaired cardiovascular reflexes, orthostatic intolerance, abnormal sweating, or peripheral autonomic involvement. Results help clinicians characterize which pathways appear affected and are interpreted alongside patient history, physical examination, medication review, and other testing rather than in isolation.

What is the most common autonomic testing protocol?

The Ewing battery is the most widely referenced cardiovascular reflex protocol. It includes heart rate response to deep breathing, Valsalva ratio, the 30:15 ratio after standing, systolic blood pressure fall on standing, and diastolic blood pressure response to handgrip. Many autonomic laboratories add QSART, thermoregulatory sweat testing, and tilt table protocols for broader assessment.³

How is HRV related to autonomic testing?

HRV is one component of autonomic testing. It measures beat-to-beat cardiac interval variation, which reflects autonomic modulation of the sinoatrial node. RMSSD and high-frequency HRV are commonly used as vagally mediated indices under controlled conditions. HRV alone cannot localize sudomotor, vasomotor, or baroreflex impairment, and it should not be read as a complete picture of autonomic function.

What is tilt table testing?

Tilt table testing evaluates cardiovascular responses to upright posture under controlled conditions. The protocol records heart rate and blood pressure continuously while the patient moves from supine to head-up tilt. It aids evaluation of orthostatic intolerance patterns, including orthostatic hypotension, vasovagal syncope, and postural tachycardia patterns, using validated clinical criteria.⁷

Can PPG replace ECG in autonomic testing?

PPG should not be treated as a universal ECG replacement in autonomic testing. ECG remains the reference standard for formal HRV analysis and reflex protocols. PPG can support continuous, longitudinal pulse-wave monitoring and controlled resting HRV estimation when signal quality is high, but motion artifact and perfusion changes limit clinical interchangeability in formal testing contexts.

What factors can affect autonomic testing results?

Age, sex, posture, breathing rate, medication use, caffeine, sleep timing, hydration, room temperature, and signal quality can all affect autonomic testing outputs. Respiratory control is especially important for HRV because breathing frequency can shift high-frequency power independent of true autonomic function. Accurate interpretation requires documented protocols and age-appropriate reference ranges.

{
“@context”: “https://schema.org”,
“@type”: “FAQPage”,
“mainEntity”: [
{
“@type”: “Question”,
“name”: “What is autonomic testing used for clinically?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Autonomic testing is used to assess autonomic nervous system function when symptoms or findings suggest impaired cardiovascular reflexes, orthostatic intolerance, abnormal sweating, or peripheral autonomic involvement. Results help clinicians characterize which pathways appear affected and are interpreted alongside patient history, physical examination, medication review, and other testing rather than in isolation.”
}
},
{
“@type”: “Question”,
“name”: “What is the most common autonomic testing protocol?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “The Ewing battery is the most widely referenced cardiovascular reflex protocol. It includes heart rate response to deep breathing, Valsalva ratio, the 30:15 ratio after standing, systolic blood pressure fall on standing, and diastolic blood pressure response to handgrip.

Many autonomic laboratories add QSART, thermoregulatory sweat testing, and tilt table protocols for broader assessment.3″
}
},
{
“@type”: “Question”,
“name”: “How is HRV related to autonomic testing?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “HRV is one component of autonomic testing. It measures beat-to-beat cardiac interval variation, which reflects autonomic modulation of the sinoatrial node. RMSSD and high-frequency HRV are commonly used as vagally mediated indices under controlled conditions. HRV alone cannot localize sudomotor, vasomotor, or baroreflex impairment, and it should not be read as a complete picture of autonomic function.”
}
},
{
“@type”: “Question”,
“name”: “What is tilt table testing?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Tilt table testing evaluates cardiovascular responses to upright posture under controlled conditions. The protocol records heart rate and blood pressure continuously while the patient moves from supine to head-up tilt.

It aids evaluation of orthostatic intolerance patterns, including orthostatic hypotension, vasovagal syncope, and postural tachycardia patterns, using validated clinical criteria.7″
}
},
{
“@type”: “Question”,
“name”: “Can PPG replace ECG in autonomic testing?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “PPG should not be treated as a universal ECG replacement in autonomic testing. ECG remains the reference standard for formal HRV analysis and reflex protocols. PPG can support continuous, longitudinal pulse-wave monitoring and controlled resting HRV estimation when signal quality is high, but motion artifact and perfusion changes limit clinical interchangeability in formal testing contexts.”
}
},
{
“@type”: “Question”,
“name”: “What factors can affect autonomic testing results?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Age, sex, posture, breathing rate, medication use, caffeine, sleep timing, hydration, room temperature, and signal quality can all affect autonomic testing outputs.

Respiratory control is especially important for HRV because breathing frequency can shift high-frequency power independent of true autonomic function. Accurate interpretation requires documented protocols and age-appropriate reference ranges.”
}
}
]
}

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“headline”: “Autonomic Testing: Common Methods and What They Show”,
“url”: “https://sensorbio.com/the-signal/autonomic-testing/”,
“datePublished”: “2026-05-14T20:50:04”,
“dateModified”: “2026-05-15T09:00:00”,
“author”: {
“@type”: “Organization”,
“name”: “Sensor Bio Editorial Team”
},
“publisher”: {
“@type”: “Organization”,
“name”: “Sensor Bio”,
“url”: “https://sensorbio.com”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://sensorbio.com/wp-content/uploads/sensor-bio-logo.png”
}
},
“description”: “Evidence-based guide on Autonomic Testing.”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://sensorbio.com/the-signal/autonomic-testing/”
}
}

Tilt-table test: what it reveals about autonomic testing of orthostatic reflexes

The tilt-table is one of the most clinically informative components of a standard autonomic testing battery. The patient lies supine on a motorised table, which tilts to 60–80 degrees head-up within a few seconds. Heart rate and beat-to-beat blood pressure are monitored continuously for 20–45 minutes. The cardiovascular response to orthostatic stress — or its absence — reveals how well sympathetic vasomotor circuits and the baroreflex arc maintain cerebral perfusion against gravity.

In a normal tilt response, heart rate rises by 10–30 beats per minute and diastolic pressure climbs slightly as venous pooling triggers baroreceptor-mediated sympathetic outflow. An exaggerated heart rate rise without hypotension — more than 30 bpm in adults, or 40 bpm in adolescents — points toward postural orthostatic tachycardia syndrome (POTS). A sustained systolic drop of ≥20 mmHg or diastolic drop ≥10 mmHg at three minutes defines orthostatic hypotension, which may be neurogenic (autonomic failure) or non-neurogenic (hypovolemia, medication effect).

Vasovagal syncope is identifiable when the passive tilt produces a late, simultaneous drop in both heart rate and blood pressure — the cardioinhibitory or vasodepressor pattern. Pharmacological provocation (sublingual nitroglycerine or isoproterenol infusion) is sometimes added to unmask latent vasovagal tendency in patients whose passive phase is negative. The tilt table alone cannot distinguish central from peripheral autonomic lesions; that localisation requires the Valsalva maneuver and sudomotor studies.

Deep breathing and Valsalva maneuver in autonomic testing

Paced deep breathing at six cycles per minute (five seconds in, five seconds out) is the gold standard for assessing vagal cardiac modulation. The metric is the expiration-to-inspiration (E:I) ratio of RR intervals, or the maximum-minus-minimum heart rate across the breathing cycle. Normal E:I ratios exceed 1.20 in younger adults; values below 1.10 indicate impaired parasympathetic cardiac innervation. Deep breathing autonomic testing is a direct, non-invasive window into the vagal limb of the baroreflex and requires no equipment beyond a pacing metronome and continuous ECG.

The Valsalva maneuver extends the evaluation to both parasympathetic and sympathetic cardiovascular arms in a single sequence. The patient exhales forcefully against 40 mmHg resistance for 15 seconds. The four phases span a mechanical blood pressure rise (I), declining pressure as venous return drops (II-early), sympathetic reflex vasoconstriction (II-late), and overshoot hypertension with reflex vagal bradycardia (IV). The Valsalva ratio — highest heart rate in phase II divided by lowest in phase IV — quantifies adrenergic and cholinergic reflexes simultaneously.

Abnormal Valsalva patterns localise lesions further. A flat phase II-late with absent phase IV overshoot implies sympathetic adrenergic failure — the hallmark of pure autonomic failure or multiple system atrophy. A preserved adrenergic response with impaired Valsalva ratio points to isolated vagal neuropathy, common in early diabetic cardiac autonomic neuropathy or post-viral autonomic syndromes. Because the Valsalva stresses the same baroreflex arc as the tilt table but via a different physiological mechanism, discordant results between the two tests narrow the diagnostic differential considerably.

QSART and sweat testing: the sudomotor arm of autonomic testing

The quantitative sudomotor axon reflex test (QSART) assesses postganglionic sympathetic sudomotor nerve function — the fibers that innervate eccrine sweat glands. Acetylcholine is delivered iontophoretically to the skin at four standard sites (forearm, proximal leg, distal leg, foot). It activates nicotinic receptors on the terminal axon, triggering an axon-reflex-mediated sweat response measured quantitatively over five minutes. QSART is the most sensitive sudomotor component of an autonomic testing panel for detecting early small-fiber neuropathy before cardiovascular reflex tests become abnormal.

Absent or reduced sweat volumes at distal sites with preserved proximal responses create a length-dependent pattern characteristic of peripheral small-fiber neuropathy, including diabetic and idiopathic neuropathies. Widespread failure across all four sites suggests a diffuse postganglionic lesion, as seen in autoimmune autonomic ganglionopathy. Sudomotor C-fibers are often damaged before large myelinated fibers, so QSART findings can be the first objective sign of nerve injury in a patient with normal nerve conduction studies.

The thermoregulatory sweat test (TST) evaluates both preganglionic and postganglionic sudomotor pathways simultaneously over the whole body. The patient is heated until core temperature rises 1°C or 30 minutes elapse; sweat distribution is visualised with an indicator powder. A patchy or absent TST pattern with preserved QSART localises the lesion to a preganglionic (central or spinal) site, because the peripheral axon reflex remains intact while the central drive to it does not. Combined TST and QSART data map the anatomical level of the sudomotor deficit.

Sympathetic versus parasympathetic function: what autonomic testing maps

A complete autonomic testing evaluation generates separate scores for parasympathetic cardiovagal function, sympathetic adrenergic function, and sympathetic sudomotor function. These three domains are independently graded and combined into a composite autonomic severity score (CASS) or equivalent. The score guides diagnosis and prognosis: mild selective parasympathetic impairment has a different clinical trajectory than severe pan-autonomic failure affecting all three domains.

Parasympathetic cardiovagal impairment — detected by the deep breathing E:I ratio and Valsalva ratio — manifests clinically as fixed resting tachycardia, exercise intolerance, and loss of the protective heart-rate deceleration that blunts ischemic risk. It is the earliest objective finding in diabetic cardiac autonomic neuropathy and is associated with increased cardiovascular mortality independent of other risk factors. Wearable HRV metrics (RMSSD, HF power) correlate with these laboratory parasympathetic indices but cannot substitute for the calibrated equipment and normative reference tables used in formal testing.

Sympathetic adrenergic impairment — identified by orthostatic blood pressure failure on tilt and by Valsalva phase II/IV — produces neurogenic orthostatic hypotension: a ≥20 mmHg systolic drop within three minutes of standing, without compensatory tachycardia. The absent heart-rate rise is the key discriminator between neurogenic and non-neurogenic causes on tilt. Neurogenic orthostatic hypotension is the dominant disabling symptom in advanced Parkinson’s disease, multiple system atrophy, and autoimmune autonomic ganglionopathy.

Clinical interpretation and limitations of autonomic testing

Results from a formal autonomic testing evaluation are interpreted against age- and sex-matched normative data because sympathetic and parasympathetic function both decline measurably with age. A QSART sweat volume normal for a 70-year-old would be flagged as reduced for a 30-year-old. Deep breathing E:I ratios fall steeply across decades; a ratio of 1.10 at age 65 may be within normal limits, whereas the same value at age 25 indicates significant vagal impairment.

Medications substantially influence results and should be tapered or withheld before the evaluation when clinically safe. Anticholinergics impair QSART and deep breathing responses; adrenergic agonists or antagonists shift tilt-table and Valsalva findings. A dedicated autonomic laboratory provides a pre-test medication protocol specific to the tests ordered. Results interpreted without knowing the patient’s current medication list are unreliable and should be treated as preliminary only.

Wearable heart rate variability data captures the same parasympathetic cardiovagal domain that deep breathing and Valsalva protocols quantify in a clinical setting. Persistent HRV suppression — particularly RMSSD below an individual’s personal baseline across several consecutive rest nights — can signal that autonomic function warrants clinical attention. However, wearable data is a screening signal, not a diagnostic test. Formal autonomic testing with standardised protocols, calibrated equipment, and age-matched reference ranges remains the benchmark for diagnosing and grading dysautonomia.